WORX (SCWorx Corp.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

WORX does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for WORX and 80,000+ other tickers.
See exactly how WORX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for WORX and 80,000+ other tickers.
SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States. The company delivers a broad spectrum of data-focused services, encompassing the repair, standardization, and interoperability of healthcare information for providers, alongside delivering sophisticated big data analytics for the…

MIDDLETON, MA, July 29, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a provider of data normalization and supply chain solutions for the healthcare industry, today announced that it has received a partial compliance letter from the Nasdaq Hearings Panel (the "Panel") confirming completion of the first benchmark for the Company's approved plan to regain compliance for continued listing on The Nasdaq Capital Market.

SCWorx Leverages Leading AI Models along with its Proprietary Healthcare Data Assets to Accelerate Data Cleansing, Enrichment, Classification and Supply Chain Intelligence SCWorx Leverages Leading AI Models along with its Proprietary Healthcare Data Assets to Accelerate Data Cleansing, Enrichment, Classification and Supply Chain Intelligence

Middleton, MA, July 08, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. , a provider of healthcare supply chain data management, interoperability and analytics solutions, today announced the deployment of its Artificial Intelligence assisted Data Management Model, a platform designed to automate portions of the SCWorx-controlled data management process and assist with the classification, normalization, enrichment and governance of healthcare supply chain product attributes.

Company Continues Expansion of Healthcare Data Management Platform as Hospitals Modernize ERP Infrastructure MIDDLETON, MA, June 30, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. a leading provider of healthcare data management, interoperability, and supply chain solutions, today announced that it has secured a new agreement with a prominent not-for-profit teaching hospital to provide data management and normalization services in support of the organization's Workday implementation initiative. Under the agreement, SCWorx will leverage its proprietary healthcare data management platform to cleanse, standardize, enrich, and optimize the Florida hospital's item master and related supply chain data assets.

MIDDLETON, MA, June 23, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a provider of data normalization and supply chain solutions for the healthcare industry, today announced that it has received a decision from the Nasdaq Hearings Panel (the "Panel") granting the Company's request to continue its listing on The Nasdaq Stock Market, subject to satisfaction of certain conditions. By way of background, trading in the Company's common stock was suspended on April 14, 2026 because the Company failed to meet the requirements of Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the "Bid Price Rule").